2026 BioX San Diego will bring together the leaders driving the future of antibody therapeutics, from early-stage discovery through late-phase development and manufacturing. Taking place in the heart of Southern California’s life science hub, this one-day summit connects biotech executives, partners, and R&D directors shaping the next wave of antibody innovation.

Track 1: Antibody Discovery & Engineering

This track explores the technologies revolutionizing antibody discovery and design. Topics include next-generation display technologies, bispecific and multispecific antibody formats. Industry experts and innovators will exchange ideas that are transforming early discovery pipelines.

Track 2: Target Validation

Understanding biological targets with precision is key to therapeutic success. This track focuses on cutting-edge methods in antibody target validation, functional screening, and immune-cell engagement profiling. Learn how advances in structural biology, multi-omics integration, and machine learning are improving target selection and translational relevance. Sessions will emphasize how smarter validation workflows are reducing attrition rates and improving success across preclinical and early clinical stages.

Track 3: Clinical & Manufacturing Innovation

From first-in-human studies to large-scale biologics manufacturing, this track examines how leading companies are redefining antibody development pipelines. Experts will discuss adaptive clinical trial design, CMC harmonization, and quality-by-design implementation. Additional sessions will spotlight automation, AI-driven process control, and the role of digital twins in scaling biologics manufacturing.